The Recall Desk
ModerateFDA (Devices)·Z-2981-2020·Announced 2020-09-23

Roche Recalls Anti-TPO Assay Kits Due to Updated Interference Claim

Roche Diagnostics is recalling 11,870 Elecsys Anti-TPO Assay kits because internal studies found the radio frequency interference claim no longer met for specific cobas e analyzers.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II and involves a labeling/claim update regarding RF interference without reported injuries or illnesses, fitting the criteria for a moderate severity voluntary precautionary recall.

Plain-English summary

Roche Diagnostics Operations, Inc. is recalling 11,870 reagent kits of the Elecsys Anti-TPO Assay, Catalog Number 06368590190. The recall affects all current and upcoming lots distributed nationwide in the United States.

The recall was initiated after recent internal verification studies determined that the current radio frequency (RF) interference claim for the assay is no longer met when used on cobas e 411, 601, and 602 analyzers. As a result, the manufacturer has updated the claim to reflect these findings.

This recall is classified as Class II by the FDA. Users of the affected kits should contact Roche Diagnostics for further instructions regarding the updated claim and any necessary actions.

The recalled product

Product
Elecsys Anti-TPO Assay on cobas e analyzers 411, 601, 602, Catalog Number 06368590190
Affected units
11,870

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All current and upcoming lots

Distribution

Distributed nationwide across the United States.